XML 43 R34.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING (Tables)
6 Months Ended
Mar. 31, 2025
SEGMENT REPORTING  
Schedule of segment information

For the six months ended March 31, 2025

Diversified

Pharmaceutical

and Allied

Insurance

    

Products*

    

AI Solutions

    

Business

    

Total

Revenue

    

$

9,631,184

    

$

1,104,733

    

$

3,575,497

    

$

14,311,414

Cost of revenue

 

8,283,104

 

772,807

 

2,744,070

 

11,799,981

Gross profit

$

1,348,080

$

331,926

$

831,427

$

2,511,433

Depreciation and amortization

$

200,236

$

146,125

$

95,729

$

442,090

Capital expenditures

$

1,035,722

$

130,835

$

$

1,166,557

*

Due to the acquisition of THE Company, the revenue has been reclassified into three categories. Among them, diversified pharmaceutical and allied products includes the former oxytetracycline & licorice products and TCMD, fertilizer, and heparin products and sausage casing.

For the six months ended March 31, 2024

Oxytetracycline 

& Licorice 

Heparin 

products and 

products and 

    

TCMD

    

Fertilizer

    

Sausage casing

    

Total

Revenue

    

$

10,755,535

$

159,199

$

1,647,865

$

12,562,599

Cost of revenue

 

9,501,675

104,591

1,542,311

11,148,577

Gross profit

$

1,253,860

$

54,608

$

105,554

$

1,414,022

Depreciation and amortization

$

444,832

$

22,857

$

87,083

$

554,772

Capital expenditures

$

685,827

$

23,771

$

76,949

$

786,547

For six months ended March 31, 2023

Oxytetracycline 

& Licorice 

Heparin 

products and 

products and 

    

TCMD

    

Fertilizer

    

Sausage casing

    

Total

Revenue

    

$

18,521,112

$

752,672

$

9,889,832

$

29,163,616

Cost of revenue

 

16,622,793

365,813

9,880,264

26,868,870

Gross profit

$

1,898,319

$

386,859

$

9,568

$

2,294,746

Depreciation and amortization

$

452,036

$

22,123

$

97,282

$

571,441

Capital expenditures

$

2,570,090

$

28,098

$

3,933

$

2,602,121

    

March 31, 

    

September 30, 

2025

2024

Total Assets

 

  

 

  

Diversified Pharmaceutical and Allied Products

$

154,006,779

$

53,003,728

AI Solutions

$

22,499,030

$

Insurance Business

$

30,887,640

$

Total

$

207,393,449

$

53,003,728